Table 1.
Clinical and demographic information.
| a) | Epilepsy (N = 369) | Migraine (N = 239) | p | |||
|---|---|---|---|---|---|---|
| Female | 200 (54.2%) | 196 (82.0%) | <0.001a* | |||
| Age (mean ± SD) | 33.9 ± 13.3 | 32.1 ± 12.2 | 0.127 | |||
| Age of disease onset (mean ± SD) | 15.1 ± 9.6 | 22.1 ± 10.5 | <0.001 | |||
| Duration of disease (mean ± SD) | 17 ± 11.6 | 15.1 ± 13.6 | <0.006 | |||
| Monthly episode frequency (mean ± SD) | 7.2 ± 24.1 | 8.6 ± 6.6 | <0.001 | |||
| b) | Brazil (N = 82) | Turkey (N = 96) | Guatemala (N = 42) | Lithuania (149) | p | |
| Epilepsy (N = 369) | Age (mean ± SD) | 38.4 ± 11.9 | 33.6 ± 10.3 | 27.9 ± 9.4 | 31.2 ± 14.7 | <0.001c |
| Duration of disease (mean ± SD) | 21.1 ± 12.8 | 14.2 ± 10.7 | 15.1 ± 9.8 | 12.6 ± 11.4 | <0.001c | |
| c) | Brazil (N = 44) | Turkey (N = 94) | Guatemala (N = 0) | Lithuania (N = 101) | p | |
| Migraine (N = 239) | Age (mean ± SD) | 39.9 ± 13.1 | 35.3 ± 10.5 | - | 25.8 ± 10.1 | <0.001c |
| Duration of disease (mean ± SD) | 21.1 ± 15.5 | 11.2 ± 10.2 | - | - | <0.001b | |
SD, standard deviation.
a
Pearson's chi-square.
b
Mann–Whitney U-test.
c
Kruskal–Wallis H-test.
*
Statistically significant (p < 0.05).